Experiment 479067
Worktypes
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Chelidonium majus (PAPAVERACEAE) |
| Citation | STANISZEWSKI,A: SLESAK,B: KOLODZIEJ,J: HARLOZINSKA-SZMYRKA,A: NOWICKY,JW:. (1992). LYMPHOCYTE SUBSETS IN PATIENTS WITH LUNG CANCER TREATED WITH THIOPHOSPHORIC ACID ALKALOID DERIVATIVES FROM CHELIDONIUM MAJUS L. (UKRAIN).. 18() |
| Amount utilized | |
| Compound isolated | |
| Disease | LYMPHOCYTE SUBSETS WERE EVALUATED IN NINE MEN WITH LUNG CANCER. OBJECTIVE TUMOR REGRESSION WAS SEEN IN 44.4% OF TREATED PATIENTS. FOUR OUT OF NINE PATIENTS (44.4%) DIED OF PROGRESSIVE DISEASE DURING THE COURSE OF THIS STUDY. |
| Dose amount | 10.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |
| Extract | THIOPHOSPHORIC ACID ALKALOID DERIVATIVE |
| Gender | MALE |